Skip to main content
SpringerLink
Log in

Mycophenolat-Mofetil und Levamisol zur Behandlung häufiger Rezidive eines idiopathischen nephrotischen Syndroms – neue Aspekte?

Mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome—new aspects?

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Gellermann J, Weber L, Pape L et al (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol Jasn 24:1689–1697. https://doi.org/10.1681/ASN.2012121200

    Article  CAS  PubMed  Google Scholar 

  2. Hackl Á, Cseprekál O, Gessner M et al (2016) Mycophenolate mofetil therapy in children with idiopathic Nephrotic syndrome: does therapeutic drug monitoring make a difference? Ther Drug Monit 38:274–279. https://doi.org/10.1097/FTD.0000000000000258

    Article  CAS  PubMed  Google Scholar 

  3. Schijvens AM, Ehren R, Weber LT, Schreuder MF (2019) The quest for optimal control of relapses in children with nephrotic syndrome. Kidney Int 95:717. https://doi.org/10.1016/j.kint.2019.01.002

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Kinder- und Jugendmedizin, Abteilung für Pädiatrische Nephrologie, Immunologie und Hypertensiologie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland

    R. Ehren

Authors
  1. R. Ehren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Ehren.

Ethics declarations

Interessenkonflikt

R. Ehren gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

T. Feldkamp, Kiel

J. Lutz, Mainz

L.T. Weber, Köln

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ehren, R. Mycophenolat-Mofetil und Levamisol zur Behandlung häufiger Rezidive eines idiopathischen nephrotischen Syndroms – neue Aspekte?. Nephrologe 14, 293–294 (2019). https://doi.org/10.1007/s11560-019-0333-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-019-0333-z

Search

Navigation